ABOUT US
At admedicum, Patient Engagement is our core business
We are currently operating in Portugal, Spain, Italy, Germany, France, United Kingdom, the Netherlands, and Belgium. Services are provided by our extended partner network in Ireland, the Nordics, Poland, Greece, South-East Europe, Austria, Switzerland, and the USA.Â
admedicum team members have the credibility, expertise, skills and experience to represent both the patient and industry perspective. We have worked on the patient side and in pharma and medtech industry positions. We understand patients and caregivers. And we understand industry.
Dr. Andreas L.G. Reimann
Managing Partner & Co-Founder
Philipp von Gallwitz
Managing Partner & Co-Founder
Dr. Roger Legtenberg
Senior Partner & Co-Owner
Ulrike Nowak
Director Patient Engagement and Head of Operations
Christian Hoenig
Director Patient Engagement
Dr. Meike Neukirchen
International Patient Engagement Manager
Robert Pleticha
International Senior Patient Engagement Manager & Head of admedicum Spain
Dr. Vera Vennedey
International Patient Engagement Manager
Dr. Andreas L.G. Reimann
Managing Partner & Co-Founder
Philipp von Gallwitz
Managing Partner & Co-Founder
Dr. Roger Legtenberg
Senior Partner & Co-Owner
Ulrike Nowak
Director Patient Engagement and Head of Operations
Christian Hoenig
Director Patient Engagement
Dr. Meike Neukirchen
International Patient Engagement Manager
Robert Pleticha
International Senior Patient Engagement Manager & Head of admedicum Spain
Dr. Vera Vennedey
International Patient Engagement Manager
Aileen Singhof, M.A.
Content Manager & Patient Engagement Consultant
BENEFITS TO CLIENTS
How we help our clients
1
Faster clinical trial recruitment and higher retention rates and involving patient experts in the trial design and execution
2
Co-create patient-reported outcomes and real-world evidence that demonstrate the actual impact on patient’s life beyond clinical data points
3
Communicate patient-relevant added-value to Health-Technology Assessors credibly and based on the voice of the patients.
4
Establish a competitive advantage with regulatory authorities and payers through the design and execution of truly patient oriented products and services
5
Through our existing, strong networks and relationships with the European patient community – both with individual patient advocates and the organisations that represent them
OUR CLIENTS
We create value by making meaningful patient access
We create value by making meaningful patient-access to our clients’ products and services possible. We achieve this by bringing patients and companies together at the right time and the right place. This way patients benefit by accessing innovative and truly patient oriented products and services. And companies increase their chance for return on investment.
Testimonials